Kieran Gostin, a Partner at Wilkinson Stekloff, has represented the government and private clients in high-profile matters for the past decade.
Recently, he has represented clients in several major class actions, including obtaining a complete defense verdict in a rare trial of a major consumer class action. At that trial, Kieran was responsible for arguing most major legal issues as well as cross examining one of three class representatives. Based on that cross examination, the jury determined that the class representative had not met her burden of proof to show that she purchased the product at issue based on the defendant’s alleged misstatements.
Following that trial win, Kieran was hired to represent a pharmaceutical company in an antitrust class action alleging that the defendant made an anticompetitive “reverse payment” to settle a generic drug manufacturer’s patent challenge. Plaintiffs claimed approximately $21 billion in trebled damages; the case settled the night before opening statements for less than 5% that amount.
In recognition of these and other successful outcomes, Kieran has received “rising star” awards from the National Law Journal, Benchmark Litigation, and Law360.
Before joining the firm, Kieran was a trial attorney in the Federal Programs Branch of the U.S. Department of Justice, where he was the lead attorney in matters challenging the legality of executive agency action, including cases involving challenges to federal healthcare and national security programs.
Updated July 2021